3 recalls found for Ascend Laboratories, LLC. Check if any of your products are affected.
Failed Dissolution Specifications
Ascend Laboratories recalled Atorvastatin Calcium Tablets USP 40 mg, 90-count (NDC 67877-513-90), 500-count (NDC 67877-513-05), and 1,000-count (NDC 67877-513-10) nationwide in the United States. The batches failed dissolution specifications. Patients should stop using the medication and contact Ascend Laboratories, LLC or their healthcare provider for guidance.
Ascend Laboratories, LLC recalls 2,256 bottles of ARIPIPRAZOLE 10 mg tablets distributed nationwide after discovering the product to be superpotent. The recall involves ARIPIPRAZOLE tablets manufactured by Alken Laboratories Ltd. in India and distributed in the United States. The recall date is August 28, 2025, with consumer notification by letter and guidance to stop use.